These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9149832)

  • 1. Evaluation of the nonorganic hearing loss suspect.
    Durrant JD; Kesterson RK; Kamerer DB
    Am J Otol; 1997 May; 18(3):361-7. PubMed ID: 9149832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies of the evaluation of cochlea function with distortion product otoacoustic emission].
    Kashiwamura M
    Hokkaido Igaku Zasshi; 1998 Nov; 73(6):641-62. PubMed ID: 10036620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distortion product otoacoustic emissions: hit and false-positive rates in normal-hearing and hearing-impaired subjects.
    Musiek FE; Baran JA
    Am J Otol; 1997 Jul; 18(4):454-61. PubMed ID: 9233485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An objective method of analyzing cochlear versus noncochlear patterns of distortion-product otoacoustic emissions in patients with acoustic neuromas.
    Telischi F
    Laryngoscope; 2000 Apr; 110(4):553-62. PubMed ID: 10763999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Otoacoustic distortion products in sensorineural hearing loss in the cochlea].
    Ricci G; Molini E; Fantera A; Manna V; Simoncelli C
    Acta Otorhinolaryngol Ital; 1996 Dec; 16(6):492-500. PubMed ID: 9381918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining the cause of hearing loss: differential diagnosis using a comparison of audiometric and otoacoustic emission responses.
    Mills DM
    Ear Hear; 2006 Oct; 27(5):508-25. PubMed ID: 16957501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distortion-product otoacoustic emissions and glycerol testing in endolymphatic hydrops.
    Magliulo G; Cianfrone G; Triches L; Altissimi G; D'Amico R
    Laryngoscope; 2001 Jan; 111(1):102-9. PubMed ID: 11192876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of hearing in patients with unilateral acoustic neuromas: the importance of the contralateral ear.
    Stipkovits EM; van Dijk JE; Graamans K
    Am J Otol; 1998 Nov; 19(6):834-9. PubMed ID: 9831164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hearing loss in vestibular schwannomas: analysis of cochlear function by means of distortion-product otoacoustic emissions.
    Ferri GG; Modugno GC; Calbucci F; Ceroni AR; Pirodda A
    Auris Nasus Larynx; 2009 Dec; 36(6):644-8. PubMed ID: 19419826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distortion product otoacoustic emissions in an industrial setting.
    Korres GS; Balatsouras DG; Tzagaroulakis A; Kandiloros D; Ferekidou E; Korres S
    Noise Health; 2009; 11(43):103-10. PubMed ID: 19414930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cochlear hearing disorders: normative distortion product otoacoustic emission measurements.
    Mills DM; Feeney MP; Gates GA
    Ear Hear; 2007 Dec; 28(6):778-92. PubMed ID: 17982366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of hearing loss using 2f2-f1 and 2f1-f2 distortion-product otoacoustic emissions.
    Fitzgerald TS; Prieve BA
    J Speech Lang Hear Res; 2005 Oct; 48(5):1165-86. PubMed ID: 16411804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of linear acceleration on distortion product otoacoustic emissions in human ears.
    Johnson RE; Allen JR; Schultz T; Liening DA; Bell AF
    Aviat Space Environ Med; 1998 Jan; 69(1):40-4. PubMed ID: 9451532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of hearing loss characteristics in a clinical population.
    Margolis RH; Saly GL
    Ear Hear; 2008 Aug; 29(4):524-32. PubMed ID: 18600134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of distortion product otoacoustic emission with tinnitus.
    Ami M; Abdullah A; Awang MA; Liyab B; Saim L
    Laryngoscope; 2008 Apr; 118(4):712-7. PubMed ID: 18176342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acoustic neuroma surgery: outcome analysis of patient-perceived disability.
    Rigby PL; Shah SB; Jackler RK; Chung JH; Cooke DD
    Am J Otol; 1997 Jul; 18(4):427-35. PubMed ID: 9233481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in distortion product otoacoustic emissions from ears with Menière's disease.
    Kusuki M; Sakashita T; Kubo T; Kyunai K; Ueno K; Hikawa C; Wada T; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():78-89. PubMed ID: 9879406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of occupational noise on pure-tone threshold and distortion product otoacoustic emissions after one workday.
    Müller J; Janssen T
    Hear Res; 2008 Dec; 246(1-2):9-22. PubMed ID: 18848612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.